Healthcare provider profile · identity verified

Mancel Talcott Mitchell, M.D.

Family Practice · PLYMOUTH, MN · NPI 1083681845

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Oxycodone Hcl	Oxycodone Hcl	498	52
Atorvastatin Calcium	Atorvastatin Calcium	425	119
Amlodipine Besylate	Amlodipine Besylate	307	90
Lisinopril	Lisinopril	302	80
Metoprolol Succinate	Metoprolol Succinate	273	82
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	233	31
Losartan Potassium	Losartan Potassium	210	64
Omeprazole	Omeprazole	181	49
Gabapentin	Gabapentin	173	37
Simvastatin	Simvastatin	170	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	164	47
Trazodone Hcl	Trazodone Hcl	142	54
Levothyroxine Sodium	Levothyroxine Sodium	138	39
Tizanidine Hcl	Tizanidine Hcl	137	31
Metformin Hcl	Metformin Hcl	118	37
Alprazolam	Alprazolam	115	21
Sertraline Hcl	Sertraline Hcl	113	32
Morphine Sulfate Er	Morphine Sulfate	108	12
Albuterol Sulfate Hfa	Albuterol Sulfate	106	38
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	102	30
Tamsulosin Hcl	Tamsulosin Hcl	101	33
Allopurinol	Allopurinol	100	27
Furosemide	Furosemide	99	35
Clonazepam	Clonazepam	92	14
Potassium Chloride	Potassium Chloride	91	23
Pantoprazole Sodium	Pantoprazole Sodium	89	30
Hydrochlorothiazide	Hydrochlorothiazide	87	26
Atenolol	Atenolol	84	26
Famotidine	Famotidine	84	31
Glimepiride	Glimepiride	84	25
Mirtazapine	Mirtazapine	82	19
Rosuvastatin Calcium	Rosuvastatin Calcium	75	27
Oxycontin	Oxycodone Hcl	73	suppressed
Fluticasone Propionate	Fluticasone Propionate	72	29
Clopidogrel	Clopidogrel Bisulfate	71	18
Duloxetine Hcl	Duloxetine Hcl	70	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	22
Lorazepam	Lorazepam	70	18
Eliquis	Apixaban	68	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	15
Torsemide	Torsemide	65	12
Trulicity	Dulaglutide	65	suppressed
Jardiance	Empagliflozin	64	16
Zolpidem Tartrate	Zolpidem Tartrate	61	14
Diazepam	Diazepam	58	11
Jantoven	Warfarin Sodium	56	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	53	17
Warfarin Sodium	Warfarin Sodium	53	13
Doxazosin Mesylate	Doxazosin Mesylate	51	16
Amoxicillin	Amoxicillin	49	24
Citalopram Hbr	Citalopram Hydrobromide	49	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	16
Baclofen	Baclofen	47	suppressed
Lovastatin	Lovastatin	46	12
Triamcinolone Acetonide	Triamcinolone Acetonide	46	20
Carvedilol	Carvedilol	44	11
Hydromorphone Hcl	Hydromorphone Hcl	43	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	43	suppressed
Finasteride	Finasteride	41	14
Ozempic	Semaglutide	39	suppressed
Prednisone	Prednisone	39	34
Meloxicam	Meloxicam	38	15
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	27
Azithromycin	Azithromycin	35	26
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Spironolactone	Spironolactone	34	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	28
Doxycycline Monohydrate	Doxycycline Monohydrate	33	23
Pravastatin Sodium	Pravastatin Sodium	33	11
Escitalopram Oxalate	Escitalopram Oxalate	32	12
Estradiol	Estradiol	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	12
Azelastine Hcl	Azelastine Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Cephalexin	Cephalexin	27	22
Celecoxib	Celecoxib	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Nitroglycerin	Nitroglycerin	24	12
Levetiracetam	Levetiracetam	23	suppressed
Nystatin	Nystatin	23	18
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Mometasone Furoate	Mometasone Furoate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Topiramate	Topiramate	20	suppressed
Zaleplon	Zaleplon	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Temazepam	Temazepam	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Fluconazole	Fluconazole	18	12
Glipizide	Glipizide	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Naloxone Hcl	Naloxone Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Belsomra	Suvorexant	13	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Methylprednisolone	Methylprednisolone	13	12
Terazosin Hcl	Terazosin Hcl	13	suppressed
Valium	Diazepam	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Ubrelvy	Ubrogepant	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error